Wells Fargo raised the firm’s price target on Corebridge (CRBG) to $42 from $37 and keeps an Overweight rating on the shares. The firm is updating its Corebridge estimates for both Q2 and the recent VA transaction. 2025/2026 EPS estimates go down mostly on loss of earnings from the VA block, while Wells’ 2027 EPS estimate and price target go higher.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge Financial’s Strategic Transaction Boosts Valuation and Shareholder Returns
- Corebridge price target raised to $44 from $43 at BMO Capital
- Corebridge Financial’s Strategic Moves and Reinsurance Agreement Justify Buy Rating
- Corebridge price target raised to $40 from $37 at Morgan Stanley
- Corebridge price target raised to $45 from $38 at Barclays